Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Bin Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1690-646X; OpenAlex author ID A5087349385. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin. Co-author DOI 10.1016/j.biomaterials.2018.11.035↗
  2. Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Co-author PMID 22320973↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao Zhi · 1 shared paper, 2019 · strength 0.09
  2. Tao Ma · 1 shared paper, 2019 · strength 0.09
  3. Wei Chen · 1 shared paper, 2019 · strength 0.09
  4. Hao Liu · 1 shared paper, 2019 · strength 0.09
  5. Tingbo Liang · 1 shared paper, 2019 · strength 0.09
  6. Sheng Li · 1 shared paper, 2011 · strength 0.02
  7. Kai Cui · 1 shared paper, 2011 · strength 0.02
  8. Wuyuan Zhou · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.